NDC Package 0074-7096-30 Qulipta

Atogepant Tablet Oral - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0074-7096-30
Package Description:
30 TABLET in 1 BOTTLE
Product Code:
Proprietary Name:
Qulipta
Non-Proprietary Name:
Atogepant
Substance Name:
Atogepant
Usage Information:
QULIPTA is indicated for the preventive treatment of episodic migraine in adults.
11-Digit NDC Billing Format:
00074709630
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
30 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 2571836 - atogepant 10 MG Oral Tablet
  • RxCUI: 2571842 - QULIPTA 10 MG Oral Tablet
  • RxCUI: 2571842 - atogepant 10 MG Oral Tablet [Qulipta]
  • RxCUI: 2571842 - Qulipta 10 MG Oral Tablet
  • RxCUI: 2571844 - atogepant 30 MG Oral Tablet
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Abbvie Inc.
    Dosage Form:
    Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    NDA215206
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    09-30-2021
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    0074-7096-044 TABLET in 1 BOTTLE

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0074-7096-30?

    The NDC Packaged Code 0074-7096-30 is assigned to a package of 30 tablet in 1 bottle of Qulipta, a human prescription drug labeled by Abbvie Inc.. The product's dosage form is tablet and is administered via oral form.

    Is NDC 0074-7096 included in the NDC Directory?

    Yes, Qulipta with product code 0074-7096 is active and included in the NDC Directory. The product was first marketed by Abbvie Inc. on September 30, 2021 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 0074-7096-30?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 30.

    What is the 11-digit format for NDC 0074-7096-30?

    The 11-digit format is 00074709630. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20074-7096-305-4-200074-7096-30